Julia P Dunn

16PUBLICATIONS
43CO-AUTHORS
PharmacogenomicsAboriginal and Torres Strait Islander sport and physical activityOptical technologyObstetrics and gynaecologyMedical biochemistry - lipids
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Apr 19, 2026
Reversion to normoglycemia with tirzepatide vs semaglutide in participants with obesity and prediabetes: a post hoc analysis of SURMOUNT-5.

|Feb 04, 2026
A treat-to-target approach for obesity management: A post hoc analysis of the SURMOUNT-5 trial.

Carel W le Roux, Luca Busetto, Louis Aronne

|Nov 04, 2025
Improved health-related quality of life with tirzepatide versus semaglutide in adults with obesity or overweight from the SURMOUNT-5 trial.

Alpana P Shukla, Julia P Dunn, Elisa Gomez Valderas

|Oct 15, 2025
Health state utilities associated with obstructive sleep apnea: preferences of patients with OSA and obesity in the UK and the US.

Katie D Stewart, Louis S Matza, Julia P Dunn

|Sep 07, 2025
Tirzepatide for the Maintenance of Body Weight Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT-MAINTAIN.

Deborah B Horn, Louis J Aronne, Sean Wharton

|Apr 25, 2025
Perceptions of anti-obesity medications among people with obesity and healthcare providers in the US: Findings from the OBSERVE Study.

Lee M Kaplan, Kimberly Gudzune, Jamy Ard

Pageof 3

Frequent Collaborators

3 joint publications

Louis J Aronne

3 joint publications

Theresa Hunter Gibble

2 joint publications

Chrisanthi A Karanikas

2 joint publications

Dachuang Cao